Guaifenesin DM

NDC 60687-828 · American Health Packaging

Generic nameGuaifenesin and Dextromethorphan

Dosage formSYRUP

RouteORAL

Active ingredient(s)GUAIFENESIN, DEXTROMETHORPHAN

Strength20; 200 mg/10mL; mg/10mL

Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]

Marketing categoryOTC MONOGRAPH DRUG

Packages

60687-828-56 — 10 TRAY in 1 CASE (60687-828-56) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-828-48) / 10 mL in 1 CUP, UNIT-DOSE (60687-828-42)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

59640-621 — guaifenesin and pseudoephedrine hydrochloride, 59726-237 — Guaifenesin, 59726-733 — Guaifenesin, Dextromethorphan HBr, 59726-734 — Guaifenesin, 59779-275 — acetaminophen, guaifenesin, phenylephrine HCl, 59779-603 — acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl, 59779-648 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 60000-057 — Guaifenesin and Dextromethorphan HBr, 60000-058 — Guaifenesin and Dextromethorphan HBr, 60687-817 — Guaifenesin and Dextromethorphan, 60687-852 — Guaifenesin, 60687-863 — Guaifenesin, 60687-874 — Guaifenesin, 61504-204 — Guaifenesin, 61787-515 — Dextromethorphan Hydrobromide and Guaifenesin, 62011-0060 — Guaifenesin, 62011-0475 — Guaifenesin and Pseudoephedrine Hydrochloride, 62207-569 — GUAIFENESIN, 62207-570 — GUAIFENESIN, 62207-827 — Guaifenesin and Pseudoephedrine HCl, +1449 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels